March 5, 2018 / 12:14 PM / 7 months ago

BRIEF-Adma Biologics Reports FY'17 Financial Results

March 5 (Reuters) - Adma Biologics Inc:

* ADMA BIOLOGICS REPORTS FULL YEAR 2017 FINANCIAL RESULTS

* ADMA BIOLOGICS - ‍BELIEVE PROGRESS MADE WITH COMPLIANCE ENHANCEMENT PROGRAM ALLOWED REMEDY OF IDENTIFIED COMPLIANCE ISSUES AT BOCA FACILITY​

* ADMA BIOLOGICS - ‍BELIEVE CO NOW READY FOR ROUTINE INSPECTION OF BOCA FACILITY BY U.S. FDA

* ADMA BIOLOGICS - ‍AT DEC 31, 2017, HAD CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS OF $43.1 MILLION, VERSUS $15.3 MILLION AT DEC 31, 2016​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below